Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
- PMID: 10985708
- DOI: 10.1016/s0735-1097(00)00873-1
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
Abstract
Objectives: We sought to delineate the angiographic findings, clinical correlates and in-hospital outcomes in patients with cardiogenic shock (CS) complicating acute myocardial infarction.
Background: Patients with CS complicating acute myocardial infarction carry a grave prognosis. Detailed angiographic findings in a large, prospectively identified cohort of patients with CS are currently lacking.
Methods: We compared the clinical characteristics, angiographic findings, and in-hospital outcomes of 717 patients selected to undergo angiography and 442 not selected, overall and by shock etiology: left or right ventricular failure versus mechanical complications.
Results: Patients who underwent angiography had lower baseline risk and a better hemodynamic profile than those who did not. Overall, 15.5% of the patients had significant left main lesions on angiography, and 53.4% had three-vessel disease, with higher rates of both for those with ventricular failure, compared with patients who had mechanical complications. Among patients who underwent angiography, those with ventricular failure had significantly lower in-hospital mortality than patients with mechanical complications (45.2% vs. 57.0%; p = 0.021). Importantly, for patients with ventricular failure, in-hospital mortality also correlated with disease severity: 35.0% for no or single-vessel disease versus 50.8% for three-vessel disease. Furthermore, mortality was associated with the culprit lesion location (78.6% in left main lesion, 69.7% in saphenous vein graft lesions, 42.4% in circumflex lesions, 42.3% in left anterior descending lesions, and 37.4% in right coronary artery lesions), and Thrombolysis In Myocardial Infarction (TIMI) flow grade (46.5% in TIMI 0/1, 49.4% in TIMI 2 and 26% in TIMI 3).
Conclusions: Patients who underwent angiographic study in the SHOCK Trial Registry had a more benign cardiac risk profile, more favorable hemodynamic findings and lower in-hospital mortality than those for whom angiograms were not obtained. Patients with CS caused by ventricular failure had more severe atherosclerosis, and a different distribution of culprit vessel involvement but lower in-hospital mortality, than those with mechanical complications. Overall in-hospital survival correlates with the extent of coronary artery obstructions, location of culprit lesion and baseline coronary TIMI flow grade.
Similar articles
-
Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK?J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1091-6. doi: 10.1016/s0735-1097(00)00888-3. J Am Coll Cardiol. 2000. PMID: 10985710 Clinical Trial.
-
Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry.J Am Coll Cardiol. 2001 Nov 1;38(5):1395-401. doi: 10.1016/s0735-1097(01)01581-9. J Am Coll Cardiol. 2001. PMID: 11691514
-
The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1071-6. doi: 10.1016/s0735-1097(00)00874-3. J Am Coll Cardiol. 2000. PMID: 10985707 Clinical Trial.
-
Cardiogenic shock from left ventricular dysfunction complicating an acute ST-elevation myocardial infarction.Am Heart Hosp J. 2009 Summer;7(1):33-8. doi: 10.15420/ahhj.2009.7.1.33. Am Heart Hosp J. 2009. PMID: 19742431 Review.
-
Current clinical management of acute myocardial infarction complicated by cardiogenic shock.Expert Rev Cardiovasc Ther. 2021 Jan;19(1):41-46. doi: 10.1080/14779072.2021.1854733. Epub 2021 Jan 19. Expert Rev Cardiovasc Ther. 2021. PMID: 33289436 Review.
Cited by
-
Sex Differences in Outcomes After Myocardial Infarction in the Community.Am J Med. 2021 Jan;134(1):114-121. doi: 10.1016/j.amjmed.2020.05.040. Epub 2020 Jul 3. Am J Med. 2021. PMID: 32622868 Free PMC article.
-
Cardiogenic Shock After Acute Myocardial Infarction: A Review.JAMA. 2021 Nov 9;326(18):1840-1850. doi: 10.1001/jama.2021.18323. JAMA. 2021. PMID: 34751704 Free PMC article. Review.
-
Culprit lesion location and outcomes in patients with multivessel disease and infarct-related cardiogenic shock: a core laboratory analysis of the CULPRIT-SHOCK trial.EuroIntervention. 2021 Aug 6;17(5):e418-e424. doi: 10.4244/EIJ-D-20-00561. EuroIntervention. 2021. PMID: 32894227 Free PMC article. Clinical Trial.
-
Cardiogenic shock in acute coronary syndromes-miles to go?Indian Heart J. 2012 Mar-Apr;64(2):159-61. doi: 10.1016/S0019-4832(12)60053-4. Epub 2012 Apr 28. Indian Heart J. 2012. PMID: 22572492 Free PMC article. No abstract available.
-
Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial.Eur J Health Econ. 2020 Nov;21(8):1197-1209. doi: 10.1007/s10198-020-01235-3. Epub 2020 Oct 7. Eur J Health Econ. 2020. PMID: 33029668 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical